GA treatment options in various steps in FDA approval process are discussed by a panel of medical experts. Ryan Haumschild, PharmD, MS, MBA: We’ve given a background of geographic atrophy [GA], but ...

Ryan Haumschild, PharmD, MS, MBA, drives an expert discussion focused on challenges associated with clinical pathway utilization in treating patients with HCC. The panel discussion focused on the ...

The fear of student debt is leading many to choose more affordable alternatives. The fear of student debt is leading many to choose more affordable alternatives to the traditional higher education ...

The Pathways for Aging program will shift care to managed health plans from the fee-for-service structure the state has been using for home and community-based services. Lawmakers and senior care ...

Famously, section 337 investigations before the U.S. International Trade Commission (ITC) are fast. By statute, the ITC must conclude section 337 investigations “at the earliest practicable time . . .

There is no common journey for a medical device start-up. Most fail, and for those that succeed follow unique paths shaped by market forces, regulatory challenges, and competitive pressures. Bringing ...